MEC Plus Full List View

MEC Plus

Update on T-cell Lymphomas
Update on T-cell Lymphomas
Yuliya Linhares, MD
Modern Challenges and New Options for B-cell NHL
Modern Challenges and New Options for B-cell NHL
Eduardo Sotomayor, MD
New Developments in CLL
New Developments in CLL
Eduardo Sotomayor, MD
New Developments in CLL
New Developments in CLL
Eduardo Sotomayor, MD
Most Relevant Data on Immunotherapy in Neo-Adjuvant, Adjuvant, and Metastatic NSCLC
Most Relevant Data on Immunotherapy in Neo-Adjuvant, Adjuvant, and Metastatic NSCLC
Luis E. Raez, MD, FACP, FCCP
Novel Mechanisms of Resistance Identified for Tyrosine Kinakse Inhibitors against ALk and Ros1 Tumors in NSCLC
Novel Mechanisms of Resistance Identified for Tyrosine Kinakse Inhibitors against ALk and Ros1 Tumors in NSCLC
Stephen Liu, MD
Advances in Targeted Therapy in Lung Cancer
Advances in Targeted Therapy in Lung Cancer
Edgardo S. Santos, MD, FACP
New Developments in Therapeutics for Metastatic Breast Cancer
New Developments in Therapeutics for Metastatic Breast Cancer
Helen Chew, MD
Breast Cancer Update in Hormone Sensitive Breast Cancer
Breast Cancer Update in Hormone Sensitive Breast Cancer
Ricardo H. Alvarez, MD
Novel Frontiers in the Use of ctDNA in Oncology
Novel Frontiers in the Use of ctDNA in Oncology
Julia Rotow, MD
Advances in Head and Neck Cancers Including Thyroid malignancies
Advances in Head and Neck Cancers Including Thyroid malignancies
Lori Wirth, MD
Gynecologic Malignancies: Targeted Therapy-IO-Chemo Combinations
Gynecologic Malignancies: Targeted Therapy-IO-Chemo Combinations
Mark S, Shahin, MD, FACOG, FACS
Updates in Kidney and Bladder Cancers
Updates in Kidney and Bladder Cancers
Jaime Merchan, MD
Updates in Cholangiocarcinoma and Pancreas Cancer
Updates in Cholangiocarcinoma and Pancreas Cancer
Jaffer A. Ajani, MD
Updates in Colorectal Cancer
Updates in Colorectal Cancer
Ahmed Zakari, MD
Updates in Prostate Cancer
Updates in Prostate Cancer
Chandler H. Park, MD, FACP